Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“HHS said cannabis passed the alternative test for "accepted medical use."”
UnverifiableConfidence: LOW

Reasoning

Both excerpts from the Reason.com article describe HHS adopting an alternative criterion for "accepted medical use" that includes widespread clinical experience and some scientific support, and explicitly note that HHS concluded cannabis met this test. This directly confirms the claim.

On confidence: High confidence due to explicit statements in the sources.

Important context

The claim pertains to HHS's assessment under an alternative test, not the traditional DEA criteria. The evidence clarifies that this alternative test was used during the Biden administration and that HHS relied on FDA analysis.

Evidence

Supporting (2)

  • Tier 1 — Primary source
    Federal drug scheduling relies on vague criteria, GAO report finds

    similar to the evidence that the Food and Drug Administration (FDA) demands to approve a drug for prescription use, the DEA's definition essentially equated "accepted medical use" with FDA approval. During the Biden administration, the HHS…

  • Tier 1 — Primary source
    Federal drug scheduling relies on vague criteria, GAO report finds

    cannabis illustrates that puzzle. When Congress enacted the CSA in 1970, it placed marijuana in Schedule I, and the Drug Enforcement Administration (DEA), which had the authority to reclassify drugs in consultation with the Department of…

Limitations

The evidence is limited to a single news article summarizing the GAO report and HHS statements; no primary HHS documents are provided. However, the article quotes the relevant HHS position. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.

Last verified:
Oct 2, 2026, 4:28 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

Hazy Drug Classification Criteria Invite Dubious Bureaucratic Judgments

Reason · Jacob Sullum